Assisted Reproductive Technology (ART) Market Outlook 2026-2034: by Product & Service (Instruments & Equipment, Reagents & Media, Software & AI Solutions), Procedure, Technology, End User

The Assisted Reproductive Technology (ART) Market is estimated at US$28.5 billion in 2026 and is projected to grow at a CAGR of 6.9% to reach US$48.6 billion by 2034.

Market Overview

The Assisted Reproductive Technology (ART) Market includes fertility treatment services, laboratory systems, medications, and procedural support used to help individuals and couples achieve pregnancy through advanced reproductive interventions. The value chain spans diagnostic assessment, fertility medications, laboratory equipment, embryo handling, clinical procedures, cryostorage services, and follow-up patient care.

Major end uses include in vitro fertilization, fertility preservation, donor programs, embryo transfer, and reproductive diagnostics support. At the same time, the market faces challenges linked to high treatment cost, emotional burden, regulatory variation, and uneven insurance coverage.

Market Segmentation

By Product & Service

• Instruments & Equipment
• Reagents & Media
• Software & AI Solutions

By Procedure

• Fresh Non-Donor
• Fresh Donor
• Frozen Donor
• Frozen Non-Donor

By Technology

• In-Vitro Fertilisation (IVF)
• Artificial Insemination (AI-IUI)
• Frozen Embryo Replacement (FER)
• Other Technology

By End User

• Fertility Clinics
• Hospitals & Surgical Centres
• Cryobanks & Research Institutes

Key Companies Analysed

• CooperSurgical
• Vitrolife
• Merck KGaA
• FUJIFILM Irvine Scientific
• Cook Medical
• Genea Biomedx
• Hamilton Thorne
• Esco Medical
• The Baker Company
• Kitazato
• Nikon
• Olympus
• Thermo Fisher Scientific
• Labotect
• Gynemed
• Rocket Medical
• Ferring Pharmaceuticals
• Progyny
• OvaScience
• Cryolab

Geographic Coverage

• North America - Market data and outlook to 2034
  • United States
  • Canada
  • Mexico
  
  
• Europe - Market data and outlook to 2034
  • Germany
  • United Kingdom
  • France
  • Italy
  • Spain
  • Netherlands
  • Switzerland
  • Poland
  • Sweden
  • Russia
  
  
• Asia-Pacific - Market data and outlook to 2034
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Malaysia
  • Vietnam
  
  
• Middle East and Africa - Market data and outlook to 2034
  • Saudi Arabia
  • South Africa
  • Iran
  • UAE
  • Egypt
  
  
• South and Central America - Market data and outlook to 2034
  • Brazil
  • Argentina
  • Chile
  • Peru
  
  

*We can include data and analysis of additional countries on demand.

Report Delivery and Support

• Updated PDF report and an MS Excel workbook containing market tables and figures.
• 7-day post-sale analyst support for clarifications and in-scope supplementary data.
• Complimentary report update covering the latest available data and relevant market developments.

This product will be delivered within 1-3 business days.